A Prospective, Natural History Study to Assess the Occurrence of HPA-1a Alloimmunization in Women Identified at Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Status: Completed
Location: See all (28) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:
• Pregnant women (≥ 18 years of age) who have provided informed consent for the study.
Locations
United States
Arizona
New Horizons Clinical Trials, LLC
Chandler
California
Zillan Clinical Research - Gardena
Gardena
Connecticut
Yale University School of Medicine
New Haven
Florida
University of Miami Miller School of Medicine
Miami
North Carolina
University of North Carolina at Chapel Hill
Chapel Hill
New Jersey
Cooper University Hospital
Camden
Robert Wood Johnson Medical School
New Brunswick
St. Peter's University Hospital
New Brunswick
Rutgers New Jersey Medical School
Newark
New York
Columbia University Irving Medical Center
New York
Icahn School of Medicine at Mount Sinai
New York
New York-Presbyterian-Queens
New York
Weill Cornell Medicine-New York Presbyterian Hospital
New York
Ohio
Ohio State University Wexner Medical Center
Columbus
Wright State Physicians Obstetrics & Gynecology
Dayton
Pennsylvania
Temple Perinatal Diagnosis Center
Philadelphia
Texas
Javara Inc. - Forest
Dallas
Javara Research Inc. - Dallas - PPDS
Houston
The University of Texas Health Science Center at Houston
Houston
Other Locations
Canada
Sunnybrook Health Sciences Centre
Toronto
Germany
Klinikum der Friedrich Schiller Universität Jena
Jena
Netherlands
Leids Universitair Medisch Centrum
Leiden
Norway
Oslo Universitetssykehus HF, Ullevål
Oslo
Universitetssykehuset Nord Norge
Tromsø
Sweden
Barnmorskestationen Rosengård
Lund
Södersjukhuset
Stockholm
Clinical Trial Consultants - Uppsala
Uppsala
United Kingdom
St. Thomas' Hospital
London
Time Frame
Start Date: 2022-03-14
Completion Date: 2025-10-10
Participants
Target number of participants: 14390
Treatments
Pregnant women
Women with higher risk of FNAIT
Related Therapeutic Areas
Sponsors
Leads: Rallybio